Clinical Trial Update: Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assesses the effect of esketamine on abdominal pain in patients with hepatocellular carcinoma undergoing transarterial chemoembolizatio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Arterial Infusion Chemotherapy
• Hepatocellular Carcinoma
• Pain
• Transarterial Chemoembolization

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: The Second Affiliated Hospital of Chongqing Medical University | Conditions: Hepatocellular Carcinoma, Transarterial Chemoembolization | Phase 4 | Status: UNKNOWN